Daewon Pharmaceutical Co., Ltd. (KRX:003220)
11,120
-310 (-2.71%)
At close: Mar 3, 2026
-20.85% (1Y)
| Market Cap | 244.98B |
| Revenue (ttm) | 590.70B |
| Net Income (ttm) | -16.04B |
| Shares Out | 21.43M |
| EPS (ttm) | -748.20 |
| PE Ratio | n/a |
| Forward PE | 32.20 |
| Dividend | 300.00 (2.62%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 51,033 |
| Average Volume | 44,670 |
| Open | 11,340 |
| Previous Close | 11,430 |
| Day's Range | 11,120 - 11,400 |
| 52-Week Range | 11,120 - 15,350 |
| Beta | 0.20 |
| RSI | 32.45 |
| Earnings Date | Mar 17, 2026 |